RESUMO
OBJECTIVE: To identify the average direct cost of the procedures performed for phlebitis treatment in patients in an Inpatient Unit and estimate the costs of the procedures performed to treat phlebitis in this unit. METHOD: A quantitative, exploratory-descriptive, single-case study. Initially, records of the procedures performed for phlebitis management were identified. Then, the cost was calculated by multiplying the execution time (timed using a chronometer) spent by nursing technicians by the unit cost of direct labor, added to the cost of materials in 2017. RESULTS: 107 phlebitis referring to 96 patients were reported. To treat the different grades of phlebitis, three procedures were carried out "application of ointment of chamomile flower extract"; "Compress application"; "Peripheral venous access installation". "Peripheral venous access installation with Íntima® catheter" corresponded to the most expensive procedure (US$ 8.90-SD=0.06). Considering the record of the execution of 656 (100%) procedures, the total average direct cost estimate corresponded to US$ 866.18/year. CONCLUSION: Knowledge about the costs of procedures can support decision making that increase allocation efficiency of consumed resources.
Assuntos
Custos e Análise de Custo , Flebite , Bandagens , Cateterismo Periférico , Humanos , Pacientes Internados , Flebite/economia , Flebite/terapiaRESUMO
This experimental and dose-response curve study aimed to carry out the quality control of the Chamomilla recutita sample, as well as to estimate the ideal dose, for anti-inflammatory effect, of the extract of its capitula, in patients with phlebitis due to peripheral intravenous infusion of antineoplastic chemotherapy and to evaluate the toxicity of this extract in human beings. The therapeutic efficacy, concerning the anti-inflammatory potential, of different doses of Chamomilla recutita extract were analyzed and compared in 25 patients. The time of regression of phlebitis was shorter for groups with 2.5 percent concentration (mean=29.2h, standard deviation = 8.98) and 5 percent concentration (mean = 38.8h, standard deviation = 17.47). Local toxicity was almost not observed. This research contributes to the innovation of the nursing clinical practice, since it suggests an alternative for the treatment of phlebitis through the clinical use of phytotherapeutic drugs.
Neste estudo, buscou-se realizar o controle de qualidade da amostra de Chamomilla recutita, bem como estimar a dose ideal, para efeito anti-inflamatório, do infuso dos seus capítulos florais, em pacientes com flebite, decorrente de infusão intravenosa periférica de quimioterapia antineoplásica, e avaliar a toxicidade desse infuso em seres humanos. Trata-se de estudo experimental, do tipo curva dose-resposta, no qual foi analisada e comparada a eficácia terapêutica, quanto ao potencial anti-inflamatório, de diferentes doses do infuso da Chamomilla recutita, em 25 pacientes. O tempo de regressão da flebite foi menor para os grupos com concentração 2,5 por cento (média=29,2h, desvio padrão=8,98) e 5 por cento (média=38,8h, desvio padrão=17,47) e praticamente não se observou toxicidade local. Esta pesquisa contribui para a inovação da prática clínica em enfermagem, uma vez que sugere alternativa para o tratamento de flebites, por meio da utilização clínica de fitoterápicos.
En este estudio, se buscó realizar el control de calidad de la muestra de Chamomilla recutita, así como estimar la dosis ideal, para efecto antiinflamatorio, de la infusión de sus inflorescencias, en pacientes con flebitis proveniente de introducción intravenosa periférica de quimioterapia antineoplásica y evaluar la toxicidad de esta infusión en los seres humanos. Se trata de estudio experimental, del tipo curva dosis-respuesta, en el cual fue analizada y comparada la eficacia terapéutica, en cuanto al potencial antiinflamatorio, de diferentes dosis de la infusión de la Chamomilla recutita en 25 pacientes. El tiempo de regresión de la flebitis fue menor para los grupos con concentración 2,5 por ciento (promedio = 29,2h, desviación estándar = 8,98) y 5 por ciento (promedio = 38,8h, desviación estándar = 17,47) y prácticamente no se observó toxicidad local. Esta investigación contribuye para la innovación de la práctica clínica en enfermería, una vez que sugiere una alternativa para el tratamiento de la flebitis por medio de la utilización clínica de fitoterapéuticos.
Assuntos
Humanos , Masculino , Feminino , Adulto , Flebite/tratamento farmacológico , Flebite/terapia , Matricaria , Plantas Medicinais , Relação Dose-Resposta a Droga , FitoterapiaRESUMO
Il sera entendu que notre article ne traitera pas du traitement homeopatique des phlebites profondes relevant d'un cas d'hospitalisation... (AU)
Assuntos
Flebite/terapia , Homeopatia , MicrocirculaçãoRESUMO
We report two patients, an 82 yeers old female and a 71 years old male, who bad a severe sepis with positive blood cultures for Staphylococcus aureis and a superficial phlebitis as the only probable focus. In both, the diagnosis of septic phlebitis was reached and an emergency phlebotomy was performed under local anaesthesia. The clinical response was satÝsfactory and the pathological examination of excised veins showed an acute exudative leukocytic thrombophlebitis
Assuntos
Humanos , Masculino , Feminino , Idoso , Flebite/terapia , Staphylococcus aureus/patogenicidade , Flebite/microbiologia , Clindamicina/uso terapêutico , Vancomicina/uso terapêutico , Cateteres de Demora/microbiologia , Cefotaxima/uso terapêutico , FlebotomiaRESUMO
La flebitis asociada a infusión es extremadamente frecuente. Este fenómeno causa, además de molestias al paciente, aumento en costos, por requerir cambios frecuentes de los accesos venosos. Se ha propuesto que la flebitis ocurre en alguna de las siguientes formas. La más frecuente, es producto del efecto químico de agentes diluídos en los fluídos de infusión forma de partículas. Un segundo tipo es el resultado delefecto físico del trauma inducido por la colocación del catéter a nivel intravenoso, y finalmente la forma microbiana, producida por bacterias introducidas en la piel durante el procedimiento o producto de fluídos contaminados.
Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Flebite/etiologia , Flebite/terapia , Infusões Intravenosas/efeitos adversos , Costa RicaRESUMO
This is a double-blind, randomized, placebo-controled, parallel study of the use of dried horse chestnut extract (Venostasin Retard) inchronic venous insufficiency of the limbs. Fifty-one patients were enrolled, divided in two groups, active (N=25) and placebo (N=26), and received treatment fortwenty days. The following parameters were evaluated: telangiectasy, perimaleolar oedema, disestesy vascular congestion, blood ebling, ocre dermatitis, ulceration, burning, lead-footfeeling, effort incapacity, and others like pains or itching. Almost all these parameters showed a statistically significant improvement or a strong trend of improvement in the active group, except telangiectasy, perimaleolar oedema and ulceration. Adverse effects were unfrecquent and mild. In conclusion, the dried horse chestnut extract (Venostasin Retard) was efficaciuos regarding to the treatment of chronic venous insuciency of the limbs, and presented hight levels of safety and tolerance